Qilian International Holding Group ltd Stock

$8.90

1.71%

Nasdaq, Fri, Dec 27 2024

ISIN

KYG7307E1070

Symbol

QLI

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Qilian International Holding Group ltd Stock price

$8.90

+3.90 78.00% 5Y

Nasdaq, Closing price Fri, Dec 27 2024

+0.15 1.71%

ISIN

KYG7307E1070

Symbol

QLI

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$64.32m
Enterprise Value	$40.55m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	37.20
EV/Sales (TTM) EV/Sales	1.36
P/S ratio (TTM) P/S ratio	2.15
P/B ratio (TTM) P/B ratio	7.33
Dividend yield	0.00%
Last dividend (FY23)	$0.25
Revenue growth (TTM) Revenue growth	-51.77%
Revenue (TTM) Revenue	$29.87m
EBIT (operating result TTM) EBIT	$-3.50m
Free Cash Flow (TTM) Free Cash Flow	$1.09m
EPS (TTM) EPS	$-0.22
Short interest	1.79%

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Get Started for Free Today

Qilian International Holding Group ltd Stock Analysis

Unlock Scores for Free

??

Financial data from Qilian International Holding Group ltd

Income Statement P&L | Balance Sheet | Cash Flow

TTM Annually

Mar '24		+/- %
Revenue	30 30	52% 52% 100%
- Direct Costs	30 30	47% 47% 102%
Gross Profit	-0.61 -0.61	113% 113% -2%
- Selling and Administrative Expenses	1.41 1.41	49% 49% 5%
- Research and Development Expense	- -	- -
EBITDA	-2.02 -2.02	200% 200% -7%
- Depreciation and Amortization	1.48 1.48	61% 61% 5%
EBIT (Operating Income) EBIT	-3.50 -3.50	422% 422% -12%
Net Profit	-7.86 -7.86	631% 631% -26%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Qilian International Holding Group ltd Stock News

Neutral

PRNewsWire

●

2 months ago

Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd.

CHENGDU, China , Oct. 29, 2024 /PRNewswire/ -- Qilian International Holding Group Ltd. ("Qilian" or the "Company") (NASDAQ: BGM) is pleased to announce that effective on October 30, 2024, the Company will change its name to "BGM Group Ltd.

Neutral

PRNewsWire

●

5 months ago

Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM"

CHENGDU, China , Aug. 13, 2024 /PRNewswire/ -- Qilian International Holding Group Ltd. ("Qilian" or the "Company") (NASDAQ: QLI), a China-based pharmaceutical and chemical products manufacturer, announced today that effective on August 11, 2024, its Class A ordinary shares will begin trading on the Nasdaq Capital Market under the ticker symbol "BGM".

Neutral

PRNewsWire

●

6 months ago

Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule

CHENGDU, China , July 12, 2024 /PRNewswire/ -- Qilian International Holding Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced that on July 10, 2024, NASDAQ notified the Company that it has determined that for the 10 consecutive business days, from June 21, 2024 to July 9, 2024, the closing bid price of the C...

Company Profile

Qilian International Holding Group Ltd. is a pharmaceutical and chemical company. It focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. The company was founded on February 7, 2019 and is headquartered in Jiuquan, China.

Head office	Cayman Islands
CEO	Chen Xin
Employees	298
Founded	2019
Website	www.bgm.ltd

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now